OGC
IDYA icon

One68 Global Capital’s IDEAYA Biosciences IDYA Stock Holding History

One68 Global Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-27,914
Closed -$209K – 36
2019
Q4 		$209K Buy
+27,914
New +$199K 0.45% 49

Other funds holding IDYA

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

One68 Global Capital's IDYA Position: Q1 2020 in Review

One68 Global Capital sold out of IDEAYA Biosciences (IDYA) in Q1 2020, closing a stake of 27,914 shares — an estimated $209K sold.

One68 Global Capital first reported a position in IDYA in Q4 2019 and held it in 1 quarter. The position peaked at $209K in Q4 2019. 28 funds tracked by Wall St. Rank hold IDYA as of Q1 2020.

  • One68 Global Capital reported no remaining IDEAYA Biosciences position as of Q1 2020 after selling out during the quarter.
  • One68 Global Capital sold 27,914 IDEAYA Biosciences shares in Q1 2020, an estimated $209K.
  • One68 Global Capital first reported a position in IDEAYA Biosciences in Q4 2019 and held it in 1 quarter.
  • One68 Global Capital's IDEAYA Biosciences position peaked at $209K in Q4 2019.
  • 28 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2020.

Based on One68 Global Capital's 13F filing for Q1 2020, filed 15 May 2020.